NeOnc posts Q3 results, confirms positive Phase 2a data for NEO100 ahead of SNONov 5Quarterly updateNEO212Neonc Technologies, Inc.Updated
NeOnc CEO buys more stock after positive NEO100 Phase 2a dataSep 17Clinical readoutNeonc Technologies, Inc.perillyl alcohol
NeOnc reports Phase 2a NEO100-01 met primary endpoint in recurrent IDH1 mutant gliomaAug 13PeopleNeonc Technologies, Inc.perillyl alcohol
NeOnc reports positive Phase 2a data for NEO100 in recurrent IDH1-mutant gliomaAug 12Clinical readoutNeonc Technologies, Inc.perillyl alcohol
NeOnc confirms August 12 topline readout for Phase 2a NEO100 glioma studyAug 10Quarterly updateNEO212Neonc Technologies, Inc.